Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 188

Results For "WHO"

2357 News Found

SeQuent Scientific appoints Rajaram Narayanan as MD & CEO
People | January 17, 2022

SeQuent Scientific appoints Rajaram Narayanan as MD & CEO

Narayanan to lead SeQuent through next phase of consolidation and growth


Strides receives USFDA approval for influenza medicine
Drug Approval | January 17, 2022

Strides receives USFDA approval for influenza medicine

The company has 271 cumulative ANDA filings with USFDA of which 243 ANDAs have been approved and 28 are pending approval


AstraZeneca and Scorpian Therapeutics partner to target novel cancer treatments
Biotech | January 14, 2022

AstraZeneca and Scorpian Therapeutics partner to target novel cancer treatments

The new collaboration focuses on a class of proteins called transcription factors, which control gene expression and can regulate important cellular processes including cell growth and survival


AliveCor’ KardiaMobile gets NICE approval to detect irregular heart rhythm symptons
Medical Device | January 13, 2022

AliveCor’ KardiaMobile gets NICE approval to detect irregular heart rhythm symptons

KardiaMobile is the first personal ECG to be recommended by NICE for use within the National Health Service (NHS) in England and Wales


Covaxin booster neutralises Omicron and Delta variants: Study
News | January 12, 2022

Covaxin booster neutralises Omicron and Delta variants: Study

The study will be published on the pre-print server, medRXiv, shortly


Merck’s KEYTRUDA shows promise as adjuvant treatment for non-small cell lung cancer
Biotech | January 11, 2022

Merck’s KEYTRUDA shows promise as adjuvant treatment for non-small cell lung cancer

First Positive Study for KEYTRUDA in Adjuvant Stage IB-IIIA NSCLC


Molnupiravir best option to treat Covid-19 now: Experts
News | January 11, 2022

Molnupiravir best option to treat Covid-19 now: Experts

Health experts of the country have pointed out that the benefits of the drug outweigh the potential risks it may have in the case of high-risk patients


Intuitive India launches Intuitive Telepresence for remote surgical case observation
Digitisation | January 11, 2022

Intuitive India launches Intuitive Telepresence for remote surgical case observation

Intuitive Telepresence (ITP), facilitates remote learning, and encourages interaction and collaboration between surgeons without the need to travel


Novartis and Molecular Partners report positive data for anti-viral Covid therapy
Biotech | January 10, 2022

Novartis and Molecular Partners report positive data for anti-viral Covid therapy

Topline results from the randomized EMPATHY Part A study in acute Covid-19 ambulatory patients comparing single intravenous doses of ensovibep, a DARPin antiviral therapeutic candidate vs. placebo, met the primary endpoint of viral load reduction over eight days


Clarivate identifies seven potential blockbuster drugs in Annual Drugs to Watch report
News | January 10, 2022

Clarivate identifies seven potential blockbuster drugs in Annual Drugs to Watch report

Despite the challenges of pandemic disruptions, drug developers advance promising therapies for conditions, including Alzheimer's, diabetes and asthma